secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001964738-25-000015
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum sells purification and filtration business to Thermo Fisher for $4.1B
-------------------------------------------------------------------------------

- Thermo Fisher to acquire Solventum's purification and filtration business for $4.1B cash, subject to customary adjustments.
- Closing expected by end of 2025; conditioned on HSR, other antitrust approvals, and no Material Adverse Effect.
- No financing condition for Thermo Fisher; Solventum grants 3-year non-compete and 2-year non-solicit post-close.
- Solventum indemnifies Thermo Fisher for pre-closing liabilities and breaches of reps; 3M must confirm tax opinion.
- Termination date November 25, 2025, subject to two 3-month extensions if regulatory conditions are unmet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000015/0001964738-25-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000015/solv-20250225.htm
  HTML page:      https://secwatch.observer/filing/0001964738-25-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer